raloxifene hydrochloride has been researched along with curcumin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Crippa, V; Messi, E; Piccolella, M; Poletti, A; Tetel, MJ | 1 |
Larsen, L; Nimick, M; Rosengren, RJ; Taurin, S | 1 |
Bardaweel, SK; Rahal, BA | 1 |
3 other study(ies) available for raloxifene hydrochloride and curcumin
Article | Year |
---|---|
Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
Topics: Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Curcumin; Estradiol; Estrogen Receptor beta; Estrogen Receptor Modulators; Fulvestrant; Genistein; Humans; Male; Prostatic Neoplasms; Raloxifene Hydrochloride; Tamoxifen | 2014 |
A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines.
Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Movement; Curcumin; Drug Synergism; Female; Human Umbilical Vein Endothelial Cells; Humans; Neoplasm Invasiveness; Raloxifene Hydrochloride; Receptors, Estrogen; Signal Transduction | 2016 |
Implications and Efficacy of Aromatase Inhibitors in Combination and Monotherapy for the Treatment of Lung Cancer.
Topics: Agar; Annexins; Apoptosis; Aromatase; Aromatase Inhibitors; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cisplatin; Curcumin; Humans; Lung Neoplasms; Propidium; Raloxifene Hydrochloride | 2022 |